Cite
HARVARD Citation
Flaxman, A. et al. (2021). Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002). Lancet. 398 (10304), pp. 981-990. [Online].